These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 24666931

  • 1. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis.
    de Boer S, Kolbe J, Wilsher ML.
    Respirology; 2014 May; 19(4):604-7. PubMed ID: 24666931
    [Abstract] [Full Text] [Related]

  • 2. Six-minute walk distance and work relationship with incremental treadmill cardiopulmonary exercise test in COPD.
    Poersch K, Berton DC, Canterle DB, Castilho J, Lopes AL, Martins J, Oliveira AR, Teixeira PJ.
    Clin Respir J; 2013 Apr; 7(2):145-52. PubMed ID: 22524795
    [Abstract] [Full Text] [Related]

  • 3. Estimating exercise capacity from walking tests in elderly individuals with stable coronary artery disease.
    Mandic S, Walker R, Stevens E, Nye ER, Body D, Barclay L, Williams MJ.
    Disabil Rehabil; 2013 Apr; 35(22):1853-8. PubMed ID: 23600709
    [Abstract] [Full Text] [Related]

  • 4. Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with noncystic fibrosis bronchiectasis.
    de Camargo AA, Amaral TS, Rached SZ, Athanazio RA, Lanza FC, Sampaio LM, de Carvalho CR, Cukier A, Stelmach R, Dal Corso S.
    Arch Phys Med Rehabil; 2014 May; 95(5):892-9. PubMed ID: 24361325
    [Abstract] [Full Text] [Related]

  • 5. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients.
    Chuang ML, Lin IF, Wasserman K.
    Respir Med; 2001 Jul; 95(7):618-26. PubMed ID: 11453321
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparing peak and submaximal cardiorespiratory responses during field walking tests with incremental cycle ergometry in COPD.
    Hill K, Dolmage TE, Woon L, Coutts D, Goldstein R, Brooks D.
    Respirology; 2012 Feb; 17(2):278-84. PubMed ID: 22008290
    [Abstract] [Full Text] [Related]

  • 10. Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients.
    Kiani A, Eslaminejad A, Shafeipour M, Razavi F, Seyyedi SR, Sharif-Kashani B, Emami H, Bakhshayesh-Karam M, Abedini A.
    Sarcoidosis Vasc Diffuse Lung Dis; 2019 Feb; 36(3):185-194. PubMed ID: 32476953
    [Abstract] [Full Text] [Related]

  • 11. Measurement properties of the 6-min walk test in individuals with exercise-induced pulmonary arterial hypertension.
    Fowler RM, Jenkins SC, Maiorana AJ, Gain KR, O'Driscoll G, Gabbay E.
    Intern Med J; 2011 Sep; 41(9):679-87. PubMed ID: 21470356
    [Abstract] [Full Text] [Related]

  • 12. Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity.
    Wallaert B, Talleu C, Wemeau-Stervinou L, Duhamel A, Robin S, Aguilaniu B.
    Respiration; 2011 Sep; 82(6):501-8. PubMed ID: 21934275
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer.
    Win T, Jackson A, Groves AM, Sharples LD, Charman SC, Laroche CM.
    Thorax; 2006 Jan; 61(1):57-60. PubMed ID: 16244091
    [Abstract] [Full Text] [Related]

  • 16. Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study.
    Arnardóttir RH, Emtner M, Hedenström H, Larsson K, Boman G.
    Respir Res; 2006 Oct 17; 7(1):127. PubMed ID: 17044921
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis.
    Magrì D, Mariotta S, Banfi C, Ricotta A, Onofri A, Ricci A, Pisani L, Cauti FM, Ghilardi S, Agostoni P.
    Respir Med; 2013 Oct 17; 107(10):1617-24. PubMed ID: 23948664
    [Abstract] [Full Text] [Related]

  • 19. Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?
    Marcellis RG, Lenssen AF, de Vries GJ, Baughman RP, van der Grinten CP, Verschakelen JA, De Vries J, Drent M.
    Lung; 2013 Feb 17; 191(1):43-52. PubMed ID: 23138855
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary function at peak exercise in patients with chronic heart failure.
    Papazachou O, Anastasiou-Nana M, Sakellariou D, Tassiou A, Dimopoulos S, Venetsanakos J, Maroulidis G, Drakos S, Roussos C, Nanas S.
    Int J Cardiol; 2007 May 16; 118(1):28-35. PubMed ID: 16893579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.